Cimetidine EP Impurity G
IMPURITIES
Product Details |
|
CAT No.# | CS-N-00305 |
Category | Impurities |
CAS | 31857-31-5 |
Molecular Weight | 112.13 |
Molecular Formula | C4H8N4 |
Purity: | >98% |
Synonyms: | N-Cyano-N',N''-dimethylguanidine;1609-06-9no-N',N''-dimethylguanidine. |
Application Notes: | Impurity in commercial preparations of Cimetidine. |
References: | Brimblecombe, R.W., et al.: J. Int. Med. Res., 3, 86 (1975), |
Shipping: | Free Shipping for worldwide on order above 2000 USD |
COA / MSDS: | View COA MSDS |
The balance used are calibrated with weights traceable to National Standards NIST |
Related Results for 'Cimetidine EP Impurity G'
-
API Standards of Cimetidine
-
Stable Isotopes of Cimetidine
-
Metabolites of Cimetidine
-
Impurities of Cimetidine
-
Glucuronides of Cimetidine
-
Intermediates of Cimetidine
Cimetidine EP Impurity G
Worldwide Suppliers of Cimetidine EP Impurity G
https://www.clearsynth.com/en/CSN00305.html
Impurities
Clearsynth
CS-N-00305
PEOPLE
ALSO SEARCHED FOR:
1.
propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylateProduct rating: 9 Cimetidine EP Impurity G based on 20 ratings
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)
This page contains information about Cimetidine EP Impurity G Cas 31857-31-5 and its Impurities.
Cimetidine EP Impurity G Cimetidine EP Impurity G Impurities of Cimetidine EP Impurity G https://www.clearsynth.com/en/CSN00305.html Impurities Clearsynth 31857-31-5 https://www.clearsynth.com/en/temp/CS-N-00305.jpg
"Products currently covered
by valid US Patents are offered for R&D use in accordance with
35 USC 271(e)+A13(1). Any patent infringement and resulting
liability is solely at buyer risk."